仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Mavrilimumab （CAM 3001） is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor （GM-CSF） receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death